NO314759B1 - Krystallinsk form av N-acetyl-neuraminsyrederivater, fremgangsmåter for fremstilling derav samt farmasöytisk formulering - Google Patents
Krystallinsk form av N-acetyl-neuraminsyrederivater, fremgangsmåter for fremstilling derav samt farmasöytisk formulering Download PDFInfo
- Publication number
- NO314759B1 NO314759B1 NO19962545A NO962545A NO314759B1 NO 314759 B1 NO314759 B1 NO 314759B1 NO 19962545 A NO19962545 A NO 19962545A NO 962545 A NO962545 A NO 962545A NO 314759 B1 NO314759 B1 NO 314759B1
- Authority
- NO
- Norway
- Prior art keywords
- crystalline form
- galacto
- glycero
- guanidino
- acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 27
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title description 7
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 239000002253 acid Substances 0.000 claims description 51
- 239000013078 crystal Substances 0.000 claims description 46
- 239000007864 aqueous solution Substances 0.000 claims description 27
- 238000002425 crystallisation Methods 0.000 claims description 12
- 230000008025 crystallization Effects 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000012296 anti-solvent Substances 0.000 claims description 10
- 239000007900 aqueous suspension Substances 0.000 claims description 6
- 230000032683 aging Effects 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 150000002576 ketones Chemical group 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 2
- 230000009466 transformation Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- 239000007787 solid Substances 0.000 description 20
- 238000003828 vacuum filtration Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910016523 CuKa Inorganic materials 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- -1 acetone Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939325841A GB9325841D0 (en) | 1993-12-17 | 1993-12-17 | Chemical compounds |
| PCT/EP1994/004154 WO1995016680A1 (en) | 1993-12-17 | 1994-12-15 | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO962545L NO962545L (no) | 1996-06-14 |
| NO962545D0 NO962545D0 (no) | 1996-06-14 |
| NO314759B1 true NO314759B1 (no) | 2003-05-19 |
Family
ID=10746778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19962545A NO314759B1 (no) | 1993-12-17 | 1996-06-14 | Krystallinsk form av N-acetyl-neuraminsyrederivater, fremgangsmåter for fremstilling derav samt farmasöytisk formulering |
Country Status (43)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| ATE305453T1 (de) * | 1995-02-27 | 2005-10-15 | Gilead Sciences Inc | Selektive inhibitoren viraler oder bakterieller neuraminidase |
| US5866601A (en) * | 1995-02-27 | 1999-02-02 | Gilead Sciences, Inc. | Carbocyclic compounds |
| US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
| PT823428E (pt) * | 1996-07-22 | 2002-04-29 | Sankyo Co | Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6451766B1 (en) | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US5859284A (en) | 1996-08-23 | 1999-01-12 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| US6518438B2 (en) | 1996-08-23 | 2003-02-11 | Gilead Sciences, Inc. | Preparation of cyclohexene carboxylate derivatives |
| US5994377A (en) | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
| US5886213A (en) * | 1997-08-22 | 1999-03-23 | Gilead Sciences, Inc. | Preparation of carbocyclic compounds |
| TW480247B (en) * | 1997-12-12 | 2002-03-21 | Gilead Sciences Inc | Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same |
| TWI291462B (en) | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| WO2013089168A1 (ja) * | 2011-12-16 | 2013-06-20 | 第一三共株式会社 | ノイラミン酸誘導体の製造方法 |
| CN109232677B (zh) * | 2018-10-18 | 2021-12-28 | 中国科学院合肥物质科学研究院 | 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU469694A1 (ru) * | 1972-12-22 | 1975-05-05 | Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им.М.В.Ломоносова | Способ получени 2-алкокси-6-алкил (арил)- -дигидропиранов |
| SK282950B6 (sk) | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| CA2081068C (en) * | 1991-10-23 | 2005-11-29 | Laurence Mark Von Itzstein | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid |
| GB9126725D0 (en) * | 1991-12-17 | 1992-02-12 | Glaxo Group Ltd | Process |
| US5639786A (en) | 1992-12-04 | 1997-06-17 | Biota Scientific Management, Pty., Ltd. | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
-
1993
- 1993-12-17 GB GB939325841A patent/GB9325841D0/en active Pending
-
1994
- 1994-12-02 TW TW083111229A patent/TW452577B/zh not_active IP Right Cessation
- 1994-12-13 IS IS4240A patent/IS4240A/is unknown
- 1994-12-15 HR HR941001A patent/HRP941001B1/xx not_active IP Right Cessation
- 1994-12-15 EP EP95904472A patent/EP0734382B1/en not_active Expired - Lifetime
- 1994-12-15 RO RO96-01195A patent/RO114792B1/ro unknown
- 1994-12-15 CA CA002177990A patent/CA2177990C/en not_active Expired - Lifetime
- 1994-12-15 CO CO94056728A patent/CO4340619A1/es unknown
- 1994-12-15 UA UA96062328A patent/UA46723C2/uk unknown
- 1994-12-15 BR BR9408340A patent/BR9408340A/pt not_active Application Discontinuation
- 1994-12-15 CN CN94194973A patent/CN1132829C/zh not_active Expired - Lifetime
- 1994-12-15 DE DE69426726T patent/DE69426726T2/de not_active Expired - Lifetime
- 1994-12-15 PE PE1994257245A patent/PE31095A1/es not_active Application Discontinuation
- 1994-12-15 PT PT95904472T patent/PT734382E/pt unknown
- 1994-12-15 MA MA23724A patent/MA23396A1/fr unknown
- 1994-12-15 RU RU96115122A patent/RU2134690C1/ru active Protection Beyond IP Right Term
- 1994-12-15 KR KR1019960703180A patent/KR100403256B1/ko not_active Expired - Lifetime
- 1994-12-15 AT AT95904472T patent/ATE199255T1/de active
- 1994-12-15 AP APAP/P/1996/000810A patent/AP9600810A0/en unknown
- 1994-12-15 EE EE9600135A patent/EE03353B1/xx unknown
- 1994-12-15 EG EG79094A patent/EG20597A/xx active
- 1994-12-15 DK DK95904472T patent/DK0734382T3/da active
- 1994-12-15 SV SV1994000076A patent/SV1994000076A/es active IP Right Grant
- 1994-12-15 HU HU9601642A patent/HU221971B1/hu active IP Right Grant
- 1994-12-15 JP JP51653195A patent/JP3317972B2/ja not_active Expired - Lifetime
- 1994-12-15 CN CNA2003101199989A patent/CN1502621A/zh active Pending
- 1994-12-15 SG SG1996007725A patent/SG46669A1/en unknown
- 1994-12-15 CZ CZ19961693A patent/CZ289234B6/cs not_active IP Right Cessation
- 1994-12-15 AP APAP/P/1994/000705A patent/AP541A/en active
- 1994-12-15 MY MYPI94003357A patent/MY116221A/en unknown
- 1994-12-15 ZA ZA9410003A patent/ZA9410003B/xx unknown
- 1994-12-15 NZ NZ277789A patent/NZ277789A/en not_active IP Right Cessation
- 1994-12-15 ES ES95904472T patent/ES2155517T3/es not_active Expired - Lifetime
- 1994-12-15 SK SK785-96A patent/SK282972B6/sk not_active IP Right Cessation
- 1994-12-15 WO PCT/EP1994/004154 patent/WO1995016680A1/en active IP Right Grant
- 1994-12-15 SI SI9430333T patent/SI0734382T1/xx unknown
- 1994-12-15 PL PL94315055A patent/PL186384B1/pl unknown
- 1994-12-16 IL IL11201194A patent/IL112011A/en not_active IP Right Cessation
- 1994-12-28 SA SA94150417A patent/SA94150417B1/ar unknown
-
1996
- 1996-06-13 FI FI962464A patent/FI120453B/fi not_active IP Right Cessation
- 1996-06-14 NO NO19962545A patent/NO314759B1/no not_active IP Right Cessation
- 1996-06-14 OA OA60842A patent/OA10325A/fr unknown
- 1996-07-08 BG BG100709A patent/BG63338B1/bg unknown
-
1997
- 1997-05-13 BR BRPP1100548-KB1A patent/BR1100548KB1/pt unknown
-
1999
- 1999-07-02 US US09/346,583 patent/US6294572B1/en not_active Expired - Lifetime
-
2000
- 2000-01-06 OA OA1200000004A patent/OA11275A/fr unknown
-
2001
- 2001-03-30 GR GR20010400531T patent/GR3035681T3/el unknown
- 2001-09-24 US US09/961,074 patent/US20020037865A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO314759B1 (no) | Krystallinsk form av N-acetyl-neuraminsyrederivater, fremgangsmåter for fremstilling derav samt farmasöytisk formulering | |
| JP3421354B2 (ja) | 結晶性セフジニルアミン塩 | |
| CA2686519C (en) | A process for the preparation of the stable, amorphous calcium salt of (6s)-n(5)-methyl-5, 6, 7, 8-tetrahydrofolic acid | |
| NO324836B1 (no) | Fremgangsmate for fremstilling av mellomproduktet 6.alfa., 9.alfa.-difluor-11.beta., 17.alfa.-dihydroksy-16.alfa.-metyl-androst-1,4-dien-3-on 17.beta.-karboksylsyre | |
| KR20210005071A (ko) | (티오)니코틴아미드 리보푸라노사이드 염 및 이의 조성물, 제조 방법, 및 용도 | |
| KR20070050449A (ko) | 메소트리온 다형체의 제조방법 | |
| HU189641B (en) | Process for preparing l-ascorbic acid | |
| GB2421024A (en) | Cefdinir crystalline form C | |
| US5489684A (en) | Process for the preparation of (6S)-5,6,7,8-tetrahydrofolic acid | |
| NO167460B (no) | Fremgangsmaate til rensing av et antibiotikumholdig materiale. | |
| AU689185C (en) | Crystalline N-acetyl neuraminic acid derivatives and processes for their preparation | |
| HK1014187B (en) | Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation | |
| HU205768B (en) | Process for purifying amphotericin b | |
| Vida et al. | Investigation in the 3, 4-dihydrocoumarin melilotic acid series | |
| US20020137954A1 (en) | Process for preparing metal ascorbate and its precursor | |
| KR960011779B1 (ko) | 세팔로스포린 결정성 수화물의 신규 제조방법 | |
| JP2000309596A (ja) | Ｌ−アスコルビン酸−２−リン酸ナトリウム塩の結晶 | |
| JPH1171387A (ja) | Ｌ−アスコルビン酸−２−リン酸ナトリウム塩の結晶 | |
| HU179752B (hu) | Eljárás S-metil-metionin-szulfóniumkloríd előállítására | |
| JPS643182B2 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |